A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Shanghai Henlius Biotech
Related studies linked through entity extraction aliases.
Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX04 Versus Avastin® in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Randomised, Double-blind, Phase I/II Study to Evaluate the PK, PD, Safety, and Efficacy Between HLX01 and Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis and Inadequate Response to Treatment With DMARDs
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Safety, Tolerability, PK and PD of HLX01 in Patients With CD20-positive B-cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Compare Efficacy, Safety and Immunogenicity of HLX02 and Herceptin in Previously Untreated HER2 +Overexpressing Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 and Rituximab in Combination With CHOP, in Previously Untreated Subjects With CD20+ DLBCL
- Status
- COMPLETED
- Phase
- PHASE3
A Pharmacokinetic and Pharmacodynamic Study Comparing HLX01 And Rituximab in Patients With CD20-Positive, B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(U.S. and German Sourced) in Healthy Chinese Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1